Search Results
68 items found for "cAMP"
- 📰 GPCR Weekly News, May 6 to 12, 2024
Neuroscience Spatiotemporal organization of prefrontal norepinephrine influences neuronal activity Transient cAMP
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Persistent cAMP Signaling by Internalized LH Receptors in Ovarian Follicles.
- Decoding β-Arrestins: from Structure to function
et al. 2021), that allow interaction with trimeric G proteins, which regulate second messengers like cAMP
- 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry. October 5-7, 2022, Verona, Italy
symposium on GPCRs in Medicinal Chemistry Dates Wednesday-Friday, 5th-7th October 2022 Place Evotec Campus
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Orally bioavailable compound 47 with favorable agonist potency (Ca2+EC50 = 24 nM, cAMPi EC50 = 6.5 nM
- 📰 GPCR Weekly News, April 29 to May 5, 2024
The story behind how Dr.GPCR came to be, the people behind the process, the great anecdotes, and what
- Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...
Vasculitis Adopted by European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP
- G.CLIPS biotech is 2 years old this month!
When I came this morning to work this is how I found my desk.
- Single-molecule counting applied to the study of GPCR oligomerization
While early evidence for the role of oligomerization in receptor signaling came from ensemble biochemical
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
A rational drug discovery campaign hinges on a deep understanding of how distinct molecules interact
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
processes of target receptor expression, purification and stabilization at the beginning of a discovery campaign The PROcisionXᵀᴹ platform (summarized in Figure 2) can be used to complete a discovery campaign within Figure 3: In a single discovery campaign (CCR5 is shown as an example), Orion’s PROcisionXᵀᴹ platform
- Therapeutic validation of an orphan G protein‐coupled receptor
study its function in both disease and physiological settings will likely potentiate drug discovery campaigns